Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryocompression With or Without Cilostazol for Prevention of Paclitaxel-Induced Peripheral Neuropathy
NCT06492070Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cilostazol in peripheral neuropathy (3 arms), sponsored by Emory University. Primary endpoints: Difference in sensation and vibration objective neuropathy scores at 12 months and Rates of impaired sensation and vibration on objective neuropathy testing and >= Grade 2 neuropathy at 12 months. Started Aug 2024; status: recruiting.
02
Drugs
cilostazol
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT06492070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06492070.